頁籤選單縮合
| 題 名 | 國際中藥品質管制及藥典編修趨勢研析=Study and Analysis on International Specification of Traditional Chinese Medicine and Editorial Trends in Pharmacopoeias |
|---|---|
| 作 者 | 王靜瓊; | 書刊名 | 中醫藥年報 |
| 卷 期 | 13 2024.10[民113.10] |
| 頁 次 | 頁(23)1-(23)139 |
| 分類號 | 414.93 |
| 關鍵詞 | 國際中藥品質研討會; 歐洲藥品質量管理局; 13B專家小組; 中藥品質管理; 臺灣中藥典編修; International symposium on the quality control of traditional Chinese medicine; European Directorate for the Quality of Medicines & Health Care; Group of experts No. 13B; The quality control of TCM; Editorial trends in Taiwan Herbal Pharmacopoeia; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 目的: 為促進臺灣中藥管理與國際接軌,藥典編修進展及最新公定檢驗技術等。 研究方法: 舉辦【2023 國際中藥品質研討會】、參加歐洲藥品質量管理局參與歐洲藥典之 13B 專家小組會議及參加國際相關研討會。 結果: 本次研討會共邀請 7 位講者,包含歐洲藥典編輯主席 Salvador ○○○教授、瑞典 Tien ○○○博士,日本 Hisayoshi ○○○博士及韓國 Seong-○○○教授;國內講者邀請 衛生福利部中醫藥司黃○○司長、臺灣中藥典召集人張○○教授、國家中醫藥研究所董 ○○教授、及臺北醫學大學 Le Thanh ○○○。當日演講實況全程錄影,並將其製成 9 個 課程影片。出席人數 109 人,其中 15 人申請藥師繼續教育學分,10 人公務人員持續教 育學分,當日活動整體滿意度達 4.6。會後舉辦一場閉門會議,討論【中藥品質管制之國 際協合化】,並帶國際專家參觀臺灣 GMP 製藥廠,促進國際交流。研究團隊亦參加 2 場 13B 專家小組會議,並於臺灣中藥典聯席會議中分享與會心得,且於基原小組編輯會議 提案討論編修建議。 結論: 本研討會邀請亞洲及歐洲中草藥品質管制專家前來分享,可以得知各國的中藥管理 制度差異,與會者受益良多,並建議未來可以辦理深度的圓桌討論會議。 |
| 英文摘要 | Aim: To promote the management of traditional Chinese medicine in Taiwan to be in line with international standards and the progress of pharmacopeia compilation and the latest official inspection technology. Methods: Organize the 【2023 International Symposium on Quality Control of Herbal Material Products】. The team will go to European Directorate for the Quality of Medicines & Health Care to participate in the 13B expert group meeting of the European Pharmacopoeia and participate in related international symposiums. Results: A total of 7 speakers were invited to this symposiu. There were 109 people in attendance. The overall satisfaction level of the day's event reached 4.6. The entire lecture was recorded live and made into 9 course videos. After the symposium, a closed-door meeting was held to discuss”International harmonization for quality control of herbal material and products”. The research team also participated in 2 13B expert group meetings, shared their experiences at the Taiwan Herbal Pharmacopoeia Joint Meeting, and discussed editing suggestions at the Origin of Source Group Editorial Meeting. Conclusion: The organizer invited experts on the quality control of Chinese herbal medicines from Asia and Europe to share their experiences. Participants could learn about the differences in the management systems of Chinese herbal medicines in different countries. The participants benefited a lot. |
本系統中英文摘要資訊取自各篇刊載內容。